CClinicalTrials.gg
Status unknownNCT02976662ASUpdated Nov 29, 2016

Artificial Shrinkage for Human Blastocyst Prior Vitrification

An interventional study of Artificial shrinkage in Vitrification, sponsored by Dar AlMaraa Center. Status unknown at 1 site in Egypt. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2016-11-29.

Sponsored by Dar AlMaraa Center · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Investigators aim to investigate the effect of elimination of blastocoelic fluid by creating a large hole in the zona pellucida at the cellular junction of the trophectoderm cells located far away from the inner cell mass with a laser pulse before vitrification.

Read the detailed description

Human blastocyst formation begins about 5 days after injecting a single sperm into an oocyte in ICSI cycle or incubation of them in IVF cycle. Human blastocyst consists of cells forming an outer layer called trophotoderm that will form the placenta in case of successful implantation, an inner cell mass which become the fetus, a fluid-filled blastocoel cavity in the center, and a surrounding zone pellucida from which the embryo hatches to implant in the uterus. Human blastocyst contains a large amount of liquid in the blastocoel, which alters the infiltration of vitrification solution during the vitrification procedures leading to ice crystal formation. Therefore, investigators need to compare blastocyst survival, clinical pregnancy and implantation rates between vitrified untreated expanded blastocysts and vitrified blastocysts with artificially eliminated blastocoels by a laser pulse prior to vitrification

02

Conditions studied

  • Vitrification
03

In context

Lead sponsor

Dar AlMaraa Center is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • BMI of ≤ 32

Exclusion criteria

Exclusion Criteria:

  • Non-expanded blastocysts.
  • Women who had uterine pathology or abnormality.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Artificial shrinkage

    Elimination of blastocoelic fluid by creating a large hole in the zona pellucida at the cellular junction of the trophectoderm cells located far away from the inner cell mass with a laser pulse before vitrification.

    Procedure: Artificial shrinkage

  • No intervention
    Without Artificial shrinkage

    Vitrify expanded blastocysts.

Interventions

  • ProcedureArtificial shrinkage

    Artificially eliminated blastocoelic fluid before vitrification procedures.

06

What researchers measure

Primary outcomes

  1. Implantation rate

    number of intrauterine gestational sacs over the total number of embryos transferred

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
  • Yasmin Magdi
    Benha, Egypt
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 29, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02976662
Lead sponsor
Dar AlMaraa Center
Collaborators
Benha University
Responsible party
Yasmin (Scientific IVF lab director, Dar AlMaraa Center) — Principal investigator
First posted
Nov 29, 2016
Start date
Sep 2016
Primary completion
Dec 2017 (estimated)
Completion
Dec 2017 (estimated)
Last update
Nov 29, 2016

Study contacts

Yasmin Magdi, M.Sc
Contact
yas.magdi@hotmail.com
+201282313979
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion